Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Sell
22
CTSO Quote, Financials, Valuation and Earnings
Last price:
$0.67
Seasonality move
:
20.99%
Day range:
$0.65 - $0.69
52-week range:
$0.60 - $1.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.20x
P/B ratio:
4.67x
Volume:
83.8K
Avg. volume:
117.2K
1-year change:
-30.82%
Market cap:
$42.1M
Revenue:
$35.6M
EPS (TTM):
-$0.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CTSO
CytoSorbents Corp.
|
$9.7M | -$0.07 | 51.05% | -41.38% | $4.92 |
|
DCTH
Delcath Systems, Inc.
|
$24.4M | $0.08 | 25.47% | 66.05% | $22.33 |
|
EXAS
EXACT Sciences Corp.
|
$832M | $0.10 | 17.71% | -84.17% | $104.56 |
|
ILMN
Illumina, Inc.
|
$1.1B | $1.11 | 1.65% | 35.24% | $131.56 |
|
NTRA
Natera, Inc.
|
$609.1M | -$0.60 | 21.37% | -21.11% | $256.95 |
|
STRR
Star Operating Cos., Inc.
|
$16.8M | -$0.76 | 50.04% | -65.48% | $12.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CTSO
CytoSorbents Corp.
|
$0.67 | $4.92 | $42.1M | -- | $0.00 | 0% | 1.20x |
|
DCTH
Delcath Systems, Inc.
|
$10.34 | $22.33 | $365.1M | 1,188.51x | $0.00 | 0% | 4.93x |
|
EXAS
EXACT Sciences Corp.
|
$102.11 | $104.56 | $19.3B | -- | $0.00 | 0% | 6.21x |
|
ILMN
Illumina, Inc.
|
$141.07 | $131.56 | $21.6B | 31.61x | $0.00 | 0% | 5.19x |
|
NTRA
Natera, Inc.
|
$234.31 | $256.95 | $32.7B | -- | $0.00 | 0% | 14.94x |
|
STRR
Star Operating Cos., Inc.
|
$10.72 | $12.00 | $36.8M | 0.75x | $0.00 | 0% | 0.51x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CTSO
CytoSorbents Corp.
|
75.25% | 1.234 | 46.74% | 1.49x |
|
DCTH
Delcath Systems, Inc.
|
0.83% | 2.032 | 0.25% | 12.82x |
|
EXAS
EXACT Sciences Corp.
|
50.33% | 1.440 | 24.46% | 2.24x |
|
ILMN
Illumina, Inc.
|
51.97% | 2.443 | 17.73% | 1.04x |
|
NTRA
Natera, Inc.
|
13.7% | 1.258 | 0.9% | 3.03x |
|
STRR
Star Operating Cos., Inc.
|
26.85% | 8.200 | 70.75% | 0.76x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CTSO
CytoSorbents Corp.
|
$6.7M | -$2.7M | -27.15% | -89.32% | -28.07% | -$2.5M |
|
DCTH
Delcath Systems, Inc.
|
$17.9M | -$388K | 1.56% | 1.59% | -1.89% | $4.3M |
|
EXAS
EXACT Sciences Corp.
|
$583.9M | $16.3M | -18.87% | -38% | 1.91% | $190M |
|
ILMN
Illumina, Inc.
|
$732M | $231M | 14.3% | 30.55% | 21.33% | $253M |
|
NTRA
Natera, Inc.
|
$384.4M | -$97.6M | -21.88% | -26.6% | -16.48% | $24.5M |
|
STRR
Star Operating Cos., Inc.
|
$5.6M | -$866K | -2.74% | -3.67% | -3.65% | -$2.4M |
CytoSorbents Corp. vs. Competitors
-
Which has Higher Returns CTSO or DCTH?
Delcath Systems, Inc. has a net margin of -33.42% compared to CytoSorbents Corp.'s net margin of 4.04%. CytoSorbents Corp.'s return on equity of -89.32% beat Delcath Systems, Inc.'s return on equity of 1.59%.
Company Gross Margin Earnings Per Share Invested Capital CTSOCytoSorbents Corp.70.28% -$0.05 $36.4M DCTHDelcath Systems, Inc.87.24% $0.02 $115.8M -
What do Analysts Say About CTSO or DCTH?
CytoSorbents Corp. has a consensus price target of $4.92, signalling upside risk potential of 632.74%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.33 which suggests that it could grow by 115.99%. Given that CytoSorbents Corp. has higher upside potential than Delcath Systems, Inc., analysts believe CytoSorbents Corp. is more attractive than Delcath Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CTSOCytoSorbents Corp.1 1 0 DCTHDelcath Systems, Inc.5 0 0 -
Is CTSO or DCTH More Risky?
CytoSorbents Corp. has a beta of 1.320, which suggesting that the stock is 31.967% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.393, suggesting its less volatile than the S&P 500 by 60.664%.
-
Which is a Better Dividend Stock CTSO or DCTH?
CytoSorbents Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CytoSorbents Corp. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTSO or DCTH?
CytoSorbents Corp. quarterly revenues are $9.5M, which are smaller than Delcath Systems, Inc. quarterly revenues of $20.6M. CytoSorbents Corp.'s net income of -$3.2M is lower than Delcath Systems, Inc.'s net income of $830K. Notably, CytoSorbents Corp.'s price-to-earnings ratio is -- while Delcath Systems, Inc.'s PE ratio is 1,188.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CytoSorbents Corp. is 1.20x versus 4.93x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTSOCytoSorbents Corp.1.20x -- $9.5M -$3.2M DCTHDelcath Systems, Inc.4.93x 1,188.51x $20.6M $830K
-
Which has Higher Returns CTSO or EXAS?
EXACT Sciences Corp. has a net margin of -33.42% compared to CytoSorbents Corp.'s net margin of -2.3%. CytoSorbents Corp.'s return on equity of -89.32% beat EXACT Sciences Corp.'s return on equity of -38%.
Company Gross Margin Earnings Per Share Invested Capital CTSOCytoSorbents Corp.70.28% -$0.05 $36.4M EXASEXACT Sciences Corp.68.64% -$0.10 $5B -
What do Analysts Say About CTSO or EXAS?
CytoSorbents Corp. has a consensus price target of $4.92, signalling upside risk potential of 632.74%. On the other hand EXACT Sciences Corp. has an analysts' consensus of $104.56 which suggests that it could grow by 2.4%. Given that CytoSorbents Corp. has higher upside potential than EXACT Sciences Corp., analysts believe CytoSorbents Corp. is more attractive than EXACT Sciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings CTSOCytoSorbents Corp.1 1 0 EXASEXACT Sciences Corp.3 18 0 -
Is CTSO or EXAS More Risky?
CytoSorbents Corp. has a beta of 1.320, which suggesting that the stock is 31.967% more volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.386%.
-
Which is a Better Dividend Stock CTSO or EXAS?
CytoSorbents Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CytoSorbents Corp. pays -- of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTSO or EXAS?
CytoSorbents Corp. quarterly revenues are $9.5M, which are smaller than EXACT Sciences Corp. quarterly revenues of $850.7M. CytoSorbents Corp.'s net income of -$3.2M is higher than EXACT Sciences Corp.'s net income of -$19.6M. Notably, CytoSorbents Corp.'s price-to-earnings ratio is -- while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CytoSorbents Corp. is 1.20x versus 6.21x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTSOCytoSorbents Corp.1.20x -- $9.5M -$3.2M EXASEXACT Sciences Corp.6.21x -- $850.7M -$19.6M
-
Which has Higher Returns CTSO or ILMN?
Illumina, Inc. has a net margin of -33.42% compared to CytoSorbents Corp.'s net margin of 13.85%. CytoSorbents Corp.'s return on equity of -89.32% beat Illumina, Inc.'s return on equity of 30.55%.
Company Gross Margin Earnings Per Share Invested Capital CTSOCytoSorbents Corp.70.28% -$0.05 $36.4M ILMNIllumina, Inc.67.59% $0.97 $5B -
What do Analysts Say About CTSO or ILMN?
CytoSorbents Corp. has a consensus price target of $4.92, signalling upside risk potential of 632.74%. On the other hand Illumina, Inc. has an analysts' consensus of $131.56 which suggests that it could fall by -6.75%. Given that CytoSorbents Corp. has higher upside potential than Illumina, Inc., analysts believe CytoSorbents Corp. is more attractive than Illumina, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CTSOCytoSorbents Corp.1 1 0 ILMNIllumina, Inc.7 8 1 -
Is CTSO or ILMN More Risky?
CytoSorbents Corp. has a beta of 1.320, which suggesting that the stock is 31.967% more volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.855%.
-
Which is a Better Dividend Stock CTSO or ILMN?
CytoSorbents Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CytoSorbents Corp. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTSO or ILMN?
CytoSorbents Corp. quarterly revenues are $9.5M, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. CytoSorbents Corp.'s net income of -$3.2M is lower than Illumina, Inc.'s net income of $150M. Notably, CytoSorbents Corp.'s price-to-earnings ratio is -- while Illumina, Inc.'s PE ratio is 31.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CytoSorbents Corp. is 1.20x versus 5.19x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTSOCytoSorbents Corp.1.20x -- $9.5M -$3.2M ILMNIllumina, Inc.5.19x 31.61x $1.1B $150M
-
Which has Higher Returns CTSO or NTRA?
Natera, Inc. has a net margin of -33.42% compared to CytoSorbents Corp.'s net margin of -14.78%. CytoSorbents Corp.'s return on equity of -89.32% beat Natera, Inc.'s return on equity of -26.6%.
Company Gross Margin Earnings Per Share Invested Capital CTSOCytoSorbents Corp.70.28% -$0.05 $36.4M NTRANatera, Inc.64.91% -$0.64 $1.5B -
What do Analysts Say About CTSO or NTRA?
CytoSorbents Corp. has a consensus price target of $4.92, signalling upside risk potential of 632.74%. On the other hand Natera, Inc. has an analysts' consensus of $256.95 which suggests that it could grow by 9.66%. Given that CytoSorbents Corp. has higher upside potential than Natera, Inc., analysts believe CytoSorbents Corp. is more attractive than Natera, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CTSOCytoSorbents Corp.1 1 0 NTRANatera, Inc.13 2 0 -
Is CTSO or NTRA More Risky?
CytoSorbents Corp. has a beta of 1.320, which suggesting that the stock is 31.967% more volatile than S&P 500. In comparison Natera, Inc. has a beta of 1.620, suggesting its more volatile than the S&P 500 by 61.981%.
-
Which is a Better Dividend Stock CTSO or NTRA?
CytoSorbents Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CytoSorbents Corp. pays -- of its earnings as a dividend. Natera, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CTSO or NTRA?
CytoSorbents Corp. quarterly revenues are $9.5M, which are smaller than Natera, Inc. quarterly revenues of $592.2M. CytoSorbents Corp.'s net income of -$3.2M is higher than Natera, Inc.'s net income of -$87.5M. Notably, CytoSorbents Corp.'s price-to-earnings ratio is -- while Natera, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CytoSorbents Corp. is 1.20x versus 14.94x for Natera, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTSOCytoSorbents Corp.1.20x -- $9.5M -$3.2M NTRANatera, Inc.14.94x -- $592.2M -$87.5M
-
Which has Higher Returns CTSO or STRR?
Star Operating Cos., Inc. has a net margin of -33.42% compared to CytoSorbents Corp.'s net margin of 14.56%. CytoSorbents Corp.'s return on equity of -89.32% beat Star Operating Cos., Inc.'s return on equity of -3.67%.
Company Gross Margin Earnings Per Share Invested Capital CTSOCytoSorbents Corp.70.28% -$0.05 $36.4M STRRStar Operating Cos., Inc.23.43% $0.86 $85.6M -
What do Analysts Say About CTSO or STRR?
CytoSorbents Corp. has a consensus price target of $4.92, signalling upside risk potential of 632.74%. On the other hand Star Operating Cos., Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 11.94%. Given that CytoSorbents Corp. has higher upside potential than Star Operating Cos., Inc., analysts believe CytoSorbents Corp. is more attractive than Star Operating Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings CTSOCytoSorbents Corp.1 1 0 STRRStar Operating Cos., Inc.1 1 0 -
Is CTSO or STRR More Risky?
CytoSorbents Corp. has a beta of 1.320, which suggesting that the stock is 31.967% more volatile than S&P 500. In comparison Star Operating Cos., Inc. has a beta of 2.711, suggesting its more volatile than the S&P 500 by 171.052%.
-
Which is a Better Dividend Stock CTSO or STRR?
CytoSorbents Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Operating Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CytoSorbents Corp. pays -- of its earnings as a dividend. Star Operating Cos., Inc. pays out 19.54% of its earnings as a dividend. Star Operating Cos., Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CTSO or STRR?
CytoSorbents Corp. quarterly revenues are $9.5M, which are smaller than Star Operating Cos., Inc. quarterly revenues of $23.7M. CytoSorbents Corp.'s net income of -$3.2M is lower than Star Operating Cos., Inc.'s net income of $3.5M. Notably, CytoSorbents Corp.'s price-to-earnings ratio is -- while Star Operating Cos., Inc.'s PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CytoSorbents Corp. is 1.20x versus 0.51x for Star Operating Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CTSOCytoSorbents Corp.1.20x -- $9.5M -$3.2M STRRStar Operating Cos., Inc.0.51x 0.75x $23.7M $3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
